Animal Allergy in Korean Pet Owners, Pet-related Industry Workers, and Laboratory Animal Reseachers

February 1, 2021 updated by: Sangmin Lee, MD, Gachon University Gil Medical Center

The Prevalence of Animal Allergy and Sensitization to Animal Allergen Among Participants in International Symposium of Korean Association for Laboratory Science and Companion Animal Exhibition

The investigators surveyed the prevalence of animal allergy and sensitization to animal allergen among participants in international symposium of Korean association for laboratory science (laboratory animal researchers) and companion animal exhibition (pet owner and pet-related industry workers).

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The investigators enrolled participants in international symposium of Korean association for laboratory science (laboratory animal researchers) and pet animal exhibition (pet owner and pet-related industry workers) after informed consents. Subjects were asked to response to questionnaires regarding their age, gender, comorbid allergic disease, family history of allergy, pet or laboratory animal, exposure time, allergic symptoms during exposure to animals. Subjects underwent skin prick test with animal allergens and other inhalant allergens.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
643

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Korea, Republic of
      • Incheon, Korea, Republic of, 405-760
        • Gachon University Gil Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Participants in international symposium of Korean association for laboratory science and companion animal exhibition

Description

Inclusion Criteria:

  • Participants in international symposium of Korean association for laboratory science and companion animal exhibition from whom informed consents were obtained.

Exclusion Criteria:

  • Subjects who reject enrollment into this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Allergic LAR
Laboratory animal researchers who experienced allergic symptom during exposure to laboratory or pet animals
Other: Animal allergy
Allergic symptom occurs during exposure to laboratory or pet animal
Non-allergic LAR
Laboratory animal researchers who did not experience allergic symptom during exposure to laboratory or pet animals
Other: Non-animal allergy
Allergic symptom does not occur during exposure to laboratory or pet animal
Allergic PO
Pet owners who experienced allergic symptom during exposure to pet animals
Other: Animal allergy
Allergic symptom occurs during exposure to laboratory or pet animal
Non-allergic PO
Pet owners who did not experience allergic symptom during exposure to pet animals
Other: Non-animal allergy
Allergic symptom does not occur during exposure to laboratory or pet animal
Allergic PIW
Allergic pet-related industry workers who experienced allergic symptom during exposure to pet animals
Other: Animal allergy
Allergic symptom occurs during exposure to laboratory or pet animal
Non-allergic PIW
Allergic pet-related industry workers who did not experience allergic symptom during exposure to pet animals
Other: Non-animal allergy
Allergic symptom does not occur during exposure to laboratory or pet animal

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Skin reactivity to animal allergens
Time Frame: The day of survey
Positivity to animal allergens in skin prick test
The day of survey

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Skin reactivity to other inhalant allergens
Time Frame: The day of survey
Positivity to other inhalant allergens in skin prick test
The day of survey
The prevalance of cormobid allergy
Time Frame: The day of survey
The prevalance of allergic rhinitis, allergic conjunctivitis, asthma, urticaria, atopic dermatitis, contact dermatitis, food allergy, drug allergy
The day of survey
Duration of animal exposure
Time Frame: The day of survey
Duration of laboratory or pet animal exposure (months)
The day of survey
Animal contact time
Time Frame: The day of survey
Animal contact time including direct contact and spatial sharing (min/day)
The day of survey
Residence of animal
Time Frame: The day of survey
Residence of animal (cage, bedroom, not bedroom but at home, outside)
The day of survey
Site of animal defecation
Time Frame: The day of survey
Site of animal defecation (outside, predetermined place at home, anywhere at home)
The day of survey
Laboratory or pet animal
Time Frame: The day of survey
Laboratory or pet animal which subject contacts
The day of survey
Severity of allergic symptom
Time Frame: The day of survey
Severity of allergic symptom (using visual analog scale) during exposure to animal
The day of survey
Duration of allergic symptom
Time Frame: The day of survey
Duration of allergic symptom during exposure to animal (min)
The day of survey
Frequency of house cleaning, bed cleansing, animal haircut, and animal hair removal from their garmet
Time Frame: The day of survey
Frequency of house cleaning, bed cleansing, animal haircut, and animal hair removal from their garmet in pet owners and pet-related industry workers
The day of survey
Use of medical service
Time Frame: The day of survey
Use of medical service including prescription and immunotherapy for animal allergy
The day of survey
Perception of animal allergy, its avoidance and immunotherapy
Time Frame: The day of survey
Agreement score (visual analog scale) to "Allergic symptom occurs during exposure to animal", "Avoidance can reduce or prevent from allergic symptom", "Immunotherapy can mitigate allergic symptom during exposure to animal"
The day of survey

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Gachon University Gil Medical Center

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Chair: Sang Pyo Lee, MD, Gachon University Gil Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
August 24, 2016

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
November 27, 2016

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
November 27, 2016

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 29, 2017

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 30, 2017

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
April 5, 2017

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
February 3, 2021

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 1, 2021

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
February 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • GBIRB2016-155

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asthma

Clinical Trials on Animal allergy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings